ibspot recalled Taoscare Motion Sickness Patches, 36-count boxes, sold in Wyoming and Virginia. The recall centers on marketing without an approved NDA or ANDA. Consumers and healthcare providers should stop using the product immediately and contact ibspot for guidance.
Marketed Without an Approved NDA/ANDA
Consumers and healthcare providers should stop using this product immediately. Contact ibspot or your healthcare provider for guidance. Notification method: E-Mail
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Taoscare Motion Sickness Patches are a transdermal patch product marketed under the ibspot brand. They are sold in 36-count boxes and intended to provide relief from motion sickness.
The defect is regulatory in nature. The product was marketed without an approved NDA/ANDA. This constitutes noncompliance with drug approval requirements rather than a physical defect in the patch.
This recall is not described as part of a broader industry pattern by the agency.
Consumers face potential regulatory risk and confusion about product status. Financial loss may occur if refunds or replacements are offered. No injuries have been reported to date.
Refer to the FDA enforcement recall page linked in the notice for official guidance and status.
Refunds or replacements, if offered, typically take several weeks to process after confirmation of eligibility.
Keep packaging, recall notices, and correspondence with the manufacturer. Take photos of packaging and product labels.
Product: Taoscare Motion Sickness Patches, 36-count boxes Brand: ibspot Manufacturer: Henan Xinyongtal Medical Technology., Ltd. Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N Sold by/Distribution: Wyoming and Virginia (WY and VA) Recall date: 2025-10-09 Recall number: D-0098-2026 Status: ACTIVE Hazard: Marketed Without an Approved NDA/ANDA Remedy: Stop using the product and contact ibspot or your healthcare provider for guidance Link to recall: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0098-2026
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.